Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial

The relationship between baseline fasting C‐peptide (FCP) and glucose control was examined in insulin‐naïve people with type 2 diabetes inadequately controlled with oral antihyperglycaemic drugs commencing basal insulin glargine 300 U/mL (Gla‐300) or 100 U/mL (Gla‐100) in the absence of sulfonylurea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496109/
https://www.ncbi.nlm.nih.gov/pubmed/32314521
http://dx.doi.org/10.1111/dom.14065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496109/
https://www.ncbi.nlm.nih.gov/pubmed/32314521
http://dx.doi.org/10.1111/dom.14065

Ejemplares similares